Health Care & Life Sciences » Biotechnology | HedgePath Pharmaceuticals Inc.

HedgePath Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
0.20
365.20
601.40
6,885.40
344.10
1,108.70
Other Current Assets
10.00
97.80
34.40
311.10
311.70
41.30
Total Current Assets
10.20
463.00
635.90
7,196.50
655.80
1,150
Total Investments and Advances
-
-
250.00
-
-
-
Other Assets
-
-
-
141.60
112.30
83
Total Assets
10.20
463.00
885.90
7,338.10
768.10
1,233
ST Debt & Current Portion LT Debt
68.40
-
-
-
-
Accounts Payable
287.10
-
-
-
-
Other Current Liabilities
420.60
400.90
461.90
308.10
601.50
Total Current Liabilities
776.10
400.90
461.90
308.10
601.50
Total Liabilities
776.10
400.90
461.90
308.10
601.50
Common Equity (Total)
765.90
62.10
424.00
7,030.00
166.60
Total Shareholders' Equity
765.80
62.10
424.00
7,030.00
166.60
Total Equity
765.80
62.10
424.00
7,030.00
166.60
Liabilities & Shareholders' Equity
10.20
463.00
885.90
7,338.10
768.10
Preferred Stock (Carrying Value)
0.00
-
-
-
-

About HedgePath Pharmaceuticals

View Profile
Address
4830 West Kennedy Boulevard
Tampa Florida 33609
United States
Employees -
Website http://www.hedgepathpharma.com
Updated 07/08/2019
HedgePath Pharmaceuticals, Inc. is clinical stage biopharmaceutical company, which discovers, develops and plans to commercialize innovative therapeutics for patients with cancer. It also explore acquiring or licensing innovative therapeutics addressing unmet needs and orphan indications beyond cancer. The company was founded on September 30, 1992 and is headquartered in Tampa, FL.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.